[Should patients receiving immunosuppressive drugs or biotherapies be vaccinated?].
La Revue du praticien
View on PubMed
Biological Response Modifier Therapy
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics
In elderly patients with AML, which patients should be considered fit or unfit for standard induction therapy?
Ronan Swords + 1 • Oct 24, 2017
Endovascular Should Be Considered First Line Therapy
David L. Dawson • Oct 20, 2017
Primary Therapy for Asymptomatic High-Risk Long QT Syndrome Patients Should NOT Be an ICD
Barry London • Oct 11, 2017